Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

value

- PMLiVE

Powerful thinking provokes change

But what does innovation really mean to us?

- PMLiVE

Defining value: has anyone asked the patient?

The real-world challenges they face give patients unique views on 'value'

- PMLiVE

Vertex’ cystic fibrosis drug too costly, says NICE

£104,000 per patient price tag is "too high" for the drug’s “modest” short term benefit

- PMLiVE

European pharma considering medicine pricing shakeup

EFPIA will later this month discuss proposals for a value-based pricing system

- PMLiVE

The future is bright

The importance of creativity and innovation in the age of the millennial

- PMLiVE

Leveraging HCP transparency insights to drive future customer investments

EFPIA’s disclosure requirements present an opportunity to assess strategy and effectiveness

China drug medicine pharma prices

Cancer drugs “less affordable in low-income countries”

China and India are among those hit hardest by the rapidly escalating price of therapies

Brain cancer glioblastoma

Tension expected as cancer market rises to $150bn-plus

IMS Health report anticipates increased demand for value-based pricing of oncology drugs

ABPI London offices

ABPI says UK role as clinical trial hub threatened by Brexit

Warns UK patients could be denied access to medical innovations as a result

- PMLiVE

An effective commercial model for cancer care

Patient-centric cancer care

- PMLiVE

Creating an engaging experience for patients

The patient experience is inextricably connected to how HCPs feel about their work and are measured and perceived, and that experience is no longer limited to the 15-minute office visit....

- PMLiVE

Stronger together

A patient-focused strategy is high on the agenda, with a top-down approach favoured by industry leaders

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links